DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cefzil (Cefprozil) - Published Studies

 
 



Cefzil Related Published Studies

Well-designed clinical trials related to Cefzil (Cefprozil)

Effect of antimicrobial therapy with amoxicillin and cefprozil on bacterial interference and beta-lactamase production in the adenoids. [2004.11]

Comparison of trimethoprim-sulfamethoxazole, cephadroxil and cefprozil as prophylaxis for recurrent urinary tract infections in children. [2004.02]

Open-Label, parallel-group, multicenter, randomized study of cefprozil versus erythromycin in children with group A streptococcal pharyngitis/tonsillitis. [2001.11]

Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis. [2001.10]

Cefprozil versus high-dose amoxicillin/clavulanate in children with acute otitis media. [2001.02]

Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients. [2000.12]

Comparative safety and efficacy of cefdinir vs amoxicillin/clavulanate for treatment of suppurative acute otitis media in children. [2000.12]

Comparison of a 5 day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbations of chronic bronchitis. [2000.06]

Efficacy and tolerability of cefprozil versus amoxicillin/clavulanate for the treatment of adults with severe sinusitis. [1998.11]

Comparison between cefprozil and penicillin to eradicate pharyngeal colonization of group A beta-hemolytic streptococci. [1998.01]

Effect of penicillin or cefprozil therapy on tonsillar flora. [1997.11]

Five-day versus ten-day treatment of acute otitis media with cefprozil. [1997.04]

Comparison of the efficacy and tolerability of once-daily ceftibuten and twice-daily cefprozil in the treatment of children with acute otitis media. [1996.09]

Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media. [1994.10]

Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections. [1994.10]

Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis. [1994.10]

Penetration of cefprozil into middle ear fluid of patients with otitis media. [1994.09]

Comparative efficacy and safety of cefprozil and amoxycillin/clavulanate in the treatment of acute otitis media in children. [1994.06]

Cefprozil versus penicillin V in treatment of streptococcal tonsillopharyngitis. [1993.08]

Oral absolute bioavailability and intravenous dose-proportionality of cefprozil in humans. [1992.09]

Review of the experience with cefprozil for the treatment of lower respiratory tract infections. [1992.06]

Clinical trials of cefprozil for treatment of skin and skin-structure infections: review. [1992.06]

Treatment of pharyngitis and tonsillitis with cefprozil: review of three multicenter trials. [1992.06]

Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media. [1992.06]

Cefprozil versus cefaclor in the treatment of mild to moderate skin and skin-structure infections. The Cefprozil Multicenter Study Group. [1992.05]

Cefprozil versus cefaclor in the treatment of acute and uncomplicated urinary tract infections. Cefprozil Multicenter Study Group. [1992.03]

Multiple-dose pharmacokinetics of cefprozil and its impact on intestinal flora of volunteers. [1992.01]

Comparative efficacy and safety of cefprozil and cefaclor in the treatment of acute uncomplicated urinary tract infections. [1991.10]

Comparative efficacy and safety of cefprozil (BMY-28100) and cefaclor in the treatment of acute group A beta-hemolytic streptococcal pharyngitis. [1991.06]

Comparative trial of cefprozil vs. amoxicillin clavulanate potassium in the treatment of children with acute otitis media with effusion. [1991.05]

Pharmacokinetics of cefprozil in infants and children. [1990.11]

Phase I study of multiple-dose cefprozil and comparison with cefaclor. [1990.06]

Well-designed clinical trials possibly related to Cefzil (Cefprozil)

Impact of amoxicillin on pneumococcal colonization compared with other therapies for acute otitis media. [2005.01]

Failure to eradicate Group A beta-haemolytic streptococci (GABHS) from the upper respiratory tract after antibiotic treatment. [2004.01]

Treatment of acute otitis media with a shortened course of antibiotics: a meta-analysis. [1998.06.03]

Pharmacodynamic activity of five oral cephalosporins against Haemophilus influenzae. [1997.03]

Other research related to Cefzil (Cefprozil)

Comparison of the effect of benzathine penicillin G, clarithromycin, cefprozil and amoxicillin/clavulanate on the bacteriological response and throat flora in group A beta hemolytic streptococcal tonsillopharyngitis. [2008.03]

Redefining the management of pediatric tonsillopharyngitis with cefprozil. [2007.12]

A rare case of hepatitis associated with cefprozil therapy. [2007]

Pharmacokinetics of cefprozil in plasma and middle ear fluid: in children undergoing treatment for acute otitis media. [2007]

A pooled analysis of seven randomized crossover studies of the palatability of cefdinir oral suspension versus amoxicillin/clavulanate potassium, cefprozil, azithromycin, and amoxicillin in children aged 4 to 8 years. [2005.12]

Effectiveness of amoxicillin, azithromycin, cefprozil and clarithromycin in the treatment of acute otitis media in children: a population-based study. [2005.03]

Pediatric tonsillopharyngitis--an evaluation of cefprozil in Indian patients. [2004.07]

Efficacy and tolerability assessment of cefprozil in children with acute otitis media. [2004.04]

Penetration of cefprozil to middle ear effusion in children with chronic otitis media with effusion. [2003.09]

[Multicenter, open clinical investigation on using cefprozil in therapy of otitis media in children] [2003]

In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin. [2002.09]

Pharmacodynamic assessment of cefprozil against Streptococcus pneumoniae: implications for breakpoint determinations. [2000.05]

[Efficacy and safety of cefprozil versus cefaclor in the treatment of acute otitis media in pediatric patients] [1998.11]

Treatment of upper and lower respiratory tract infections: clinical trials with cefprozil. [1998.08]

Cefprozil and respiratory tract infections in children. [1998.08]

Cefprozil treatment of persistent and recurrent acute otitis media. [1997.05]

Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten. [1996.03]

Cefprozil, a new cephalosporin: its use in various clinical trials. [1995.03]

Comparative studies of cefprozil in the management of skin and soft-tissue infections. [1994.10]

Comparative microbiological activity and pharmacokinetics of cefprozil. [1994.10]

Serum sickness-like reactions associated with cefprozil therapy. [1994.08]

Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium. [1994.06]

Antimicrobial drug suspensions: a blinded comparison of taste of twelve common pediatric drugs including cefixime, cefpodoxime, cefprozil and loracarbef. [1994.02]

Predictive accuracy of disk diffusion test for Proteus vulgaris and Providencia species against five newer orally administered cephalosporins, cefdinir, cefetamet, cefprozil, cefuroxime, and loracarbef. [1994.02]

Susceptibility of United States clinical trial isolates to cefprozil and cefaclor. [1994.02]

Effects of time of administration and posture on the pharmacokinetics of cefprozil. [1993.09]

Review of in vitro activity, pharmacokinetic characteristics, safety, and clinical efficacy of cefprozil, a new oral cephalosporin. [1993.09]

Cefprozil. [1993.03]

Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential. [1993.02]

[Pharmacokinetic and clinical studies of cefprozil fine granules in children] [1992.12]

[Therapeutic effects of cefprozil in the treatment of various infectious diseases in children] [1992.12]

[Basic and clinical studies on cefprozil in pediatrics] [1992.12]

[Clinical study on cefprozil fine granules] [1992.12]

[Clinical evaluation of cefprozil granules in pediatric field] [1992.12]

[Clinical studies on cefprozil in pediatrics] [1992.12]

[Clinical studies on cefprozil granules] [1992.12]

[Clinical evaluation of a new oral cephalosporin, cefprozil, in pediatrics] [1992.12]

[Clinical evaluation of cefprozil in children] [1992.12]

[Pharmacokinetic and clinical studies on cefprozil granules in the pediatric field] [1992.12]

[Laboratory and clinical studies of cefprozil in pediatric field] [1992.11]

[Pharmacokinetic, bacteriological and clinical studies on cefprozil in pediatric patients] [1992.11]

[Laboratory and clinical studies on cefprozil in the field of pediatrics] [1992.11]

[Clinical study on cefprozil in pediatrics] [1992.11]

[Laboratory and clinical studies on cefprozil granules in pediatrics] [1992.11]

[Clinical studies on cefprozil granules in pediatrics] [1992.11]

[Clinical evaluation of a new oral cephem, cefprozil in children] [1992.11]

[Pharmacokinetics of cefprozil in infant and adult beagle dogs] [1992.11]

[Overall clinical evaluation of cefprozil against infections in pediatric fields. Pediatric Study Group for Cefprozil] [1992.11]

[The influence of cefprozil on intestinal bacterial flora] [1992.11]

Short report: cefprozil for the eradication of Helicobacter pylori infection. [1992.08]

Safety profile of cefprozil. [1992.06]

Pharmacology and pharmacokinetics of cefprozil. [1992.06]

Effect of antacid on the bioavailability of cefprozil. [1992.05]

Absolute bioavailability of cefprozil after oral administration in beagles. [1992.03]

A noncomparative study of cefprozil at two dose levels in the treatment of acute uncomplicated bacterial sinusitis. [1992.03]

Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in women. [1991.09]

Pharmacokinetics of cefprozil in healthy subjects and patients with hepatic impairment. [1991.04]

Other possibly related research studies

[Resistance surveillance of common community respiratory pathogens isolated in China, 2002 - 2003] [2004.03]

Palatability of oral antibiotics among children in an urban primary care center. [2000.03]

Bacterial interference in the nasopharynx following antimicrobial therapy of acute otitis media. [1998.04]

In vitro activities of oral antimicrobial agents against penicillin-resistant Streptococcus pneumoniae: implications for outpatient treatment. [1997.06]

Pott's puffy tumor due to Haemophilus influenzae: case report and review. [1996.12]

A critical review of the new oral cephalosporins. Considerations and place in therapy. [1994.11]

[Effect of BMY-28100 on bacterial flora in adult human feces] [1990.11]

[Studies on the pharmacokinetics of BMY-28100 (II)] [1990.07]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012